Apotex asks Supreme Court to overturn Teva ‘Bendeka’ ruling
21-12-2021
Merck Sharp & Dohme fails to secure new nasal spray trial
12-02-2018
Endo sues Lupin over nasal spray
02-08-2017
Sirada Wichitaphornkun / Shutterstock.com
Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro (azelastine) patents.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Bayer Healthcare, Meda Pharmaceuticals, Apotex, allergy treatment, US District Court for the District of Delaware, FDA
